Open access · CC-BY via OpenAlex

First evidence that senolytics are effective at decreasing senescent cells in humans

EBioMedicine · 2020 · ▲ 58 citations

Cellular senescence Chronic inflammation Senolytics Non-human primate Human Mouse

Abstract

The increasing life expectancy of the world population has become an economic and global public health problem. Increased life expectancy tracks with a higher incidence of multiple chronic conditions, despite unprecedented advances in prevention, diagnostics, and treatment. Ageing is the greatest risk factor for many life-threatening disorders, including cardiovascular disease, neurodegeneration and cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.ebiom.2019.09.053
Canonical: link ↗
Fetched: 2026-07-29 MST

Cite this

APA

Ellison, G.M. (2020). First evidence that senolytics are effective at decreasing senescent cells in humans. <em>EBioMedicine</em>. https://doi.org/10.1016/j.ebiom.2019.09.053

Vancouver

Ellison GM. First evidence that senolytics are effective at decreasing senescent cells in humans. EBioMedicine. 2020. doi:10.1016/j.ebiom.2019.09.053.

BibTeX

@article{georgina2020Firste, title = {First evidence that senolytics are effective at decreasing senescent cells in humans}, author = {Georgina M. Ellison}, journal = {EBioMedicine}, year = {2020}, doi = {10.1016/j.ebiom.2019.09.053}, }